Experience from Turkish centers participating in the Early Access Program (EAP):Preliminary real-world safety data of nivolumab (nivo) combined withipilimumab (ipi) in pre-treated advanced melanoma patients


KARADURMUŞ N., ŞENDUR M. A. N., KARACA Ş. B., ÖLMEZ Ö. F., HACIBEKİROĞLU İ., COŞKUN H. Ş., ...Daha Fazla

journal of oncological scinece, 2019 (Hakemli Dergi)